Understanding virulence is vital for the development of novel therapeutics to target infections with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), which cause an ongoing epidemic in the United States and are on a global rise. However, what defines virulence particularly of global CA-MRSA lineages is poorly understood. Threatening a vast population, the predominant Asian CA-MRSA lineage ST59 is of major epidemiological importance. However, there have been no molecular analyses using defined virulence gene deletion mutants in that lineage as of yet. Here, we compared virulence in skin, lung, and blood infection models of ST59 CA-MRSA isolates with geographically matched hospital-associated MRSA isolates. We selected a representative ST59 CA-MRSA isolate based on toxin expression and virulence characteristics, and produced isogenic gene deletion mutants of important CA-MRSA virulence determinants (α-toxin, PSM α, Agr) in that isolate for in-vitro and in-vivo analyses. Our results demonstrate strongly enhanced virulence of ST59 CA-MRSA over hospitalassociated lineages, supporting the notion that enhanced virulence is characteristic for CA-MRSA. Furthermore, they show strong and significant contribution of Agr, α-toxin, and PSMα to pathogenesis of ST59 CA-MRSA skin, lung, and blood infection, emphasizing the value of drug development efforts targeted toward those virulence determinants.
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The other hypothesis explains enhanced virulence by increased expression of cytolytic toxins, including α -toxin and phenol-soluble modulins (PSMs) α , whose genes are present in virtually all S. aureus strains [7] [8] [9] . Importantly, our notions about the basis of virulence of CA-MRSA are based almost exclusively on studies of clone USA300. However, globally, CA-MRSA infections are due to different lineages with specific lineages frequently dominating in a given geographic location. The most widespread CA-MRSA clone in large parts of Asia is sequence type (ST) 59 10 . Considering the high population in the areas where ST59 is the predominant CA-MRSA clone, this clone may threaten a greater number of people than USA300. However, with few exceptions [11] [12] [13] , global CA-MRSA clones have not been investigated on the molecular level, such as by using gene deletions in virulence determinants.
Here we performed detailed molecular investigation of ST59 CA-MRSA. We compared virulence to geographically matched HA-MRSA clones and selected a representative clone based on virulence and virulence factor expression to produce isogenic gene deletion mutants in premier CA-MRSA virulence determinants, which we analyzed using animal models of skin, lung, and blood infection as the most prominent CA-MRSA disease manifestations.
Results
To investigate the virulence characteristics of the CA-MRSA ST59 lineage, we analyzed all infectious ST59 CA-MRSA isolates (n = 25) obtained in 2014 at Renji hospital, Shanghai, a large teaching hospital with more than 20,000 admissions per day from the entire Shanghai metropolitan area. We compared them with all HA-MRSA isolates of ST5 (n = 141) and ST239 (n = 103) obtained at the same hospital in the same time. ST5 and ST239 are reportedly the most frequent HA-MRSA types in China 14 , which was also the case in our hospital: ST5 caused 48% and ST239 44% of total HA-MRSA infections between 2005 and 2014 at Renji hospital.
To obtain a representative and experimentally manageable subset of isolates, we first determined production levels of PSMα 3 in all isolates from SSTI and lung infections, which accounted for the vast majority of infections by those isolates (ST59: SSTI 76%, lung infections 16%; ST5: SSTI 11%, lung infections 66%; ST239: SSTI 15%; lung infections 62%) (Fig. 1a) . PSMα 3 is the most potent PSM in S. aureus and a widespread S. aureus virulence determinant 7, 8 . Together with δ -toxin, whose relative production levels reflected those of PSMα 3 ( Fig. 1a) , it is also a direct indicator of the activity of the main global virulence regulator system Agr 15, 16 . Isolates for further in-vitro and in-vivo experiments, which showed comparable in-vitro growth patterns (Fig. 1b) , were selected so that average PSMα 3 production levels were close to those of all isolates within a group (Fig. 1a) . Thus, average virulence potentials of selected subsets should adequately reproduce those of the entire groups.
First, we analyzed whether CA-MRSA ST59 isolates have increased virulence, as reported for USA300 and other CA-MRSA clone 1, 7, 11, 17 , in skin and lung infection models as compared to the HA-MRSA isolates. Notably, we only used isolates that originated from the corresponding type of human infection. In the skin infection model, abscesses caused by ST59 isolates were significantly larger than those caused by ST5 and ST239 isolates (Fig. 2a,b) . Histological examinations showed more extensive inflammation with leukocyte infiltration, destruction of the skin structure, and inflammation that extended to dermal tissue (Fig. 2b) . In the lung infection model, lung pathology as measured by lung weight and bacterial load was significantly more pronounced in ST59 than in ST5 and ST239 isolates (Fig. 3a,b) , which was reflected by macroscopic lung examination and histopathology results (Fig. 3c ). Mice infected with ST59 showed extensive inflammation with disruption of pulmonary architecture, hemorrhagic infiltration, and influx of leukocytes. Notably, pathology in skin and lung infection models of ST59 isolates reached levels similar to those caused by the USA300 clone LAC (Figs 2 and 3 ). These findings demonstrate pronounced virulence of ST59 CA-MRSA isolates.
To understand the basis of virulence in ST59 CA-MRSA, we first considered the most important reported mobile genetic element-encoded virulence determinants of CA-MRSA, PVL and the arginine mobile genetic element (ACME) 6, 18, 19 . PVL genes were only present in a minority of our 2014 ST59 CA-MRSA isolates (36%), indicating that PVL is not a determining general factor of enhanced virulence of ST59 CA-MRSA. Similarly, ACME, shown to contribute to the virulence of USA300 18 , was absent from the ST59 isolates. Therefore, we hypothesized that enhanced virulence of ST59 CA-MRSA is due to increased expression of core-genome encoded virulence determinants. We determined expression levels of the two genome-encoded toxins most frequently linked to CA-MRSA virulence, α -toxin (Hla) and PSMα peptides 8, 9 , and of the Agr system controlling expression of these toxins 20 . Expression levels of the hla and psmα genes as well as that of RNAIII, the intracellular effector of Agr 21 , were significantly increased in the ST59 versus ST5 and ST239 isolates (Fig. 4) , which is in accordance with the observed significantly increased amounts of PSMα 3 and δ -toxin in culture filtrates (Fig. 1a) . These results suggest that α -toxin, PSMα , and Agr expression contribute to the observed increased virulence potential of the ST59 CA-MRSA isolates.
To directly analyze the importance of PSMα peptides, α -toxin, and Agr in the Chinese ST59 CA-MRSA strain background, we produced isogenic gene deletion mutants in a representative isolate (as judged by virulence in the skin infection model, Fig. 2a ). We first confirmed the impact of Agr regulation on hla and psmα expression, which was much stronger for psmα , most likely owing to the described exceptionally direct mechanism of psmα regulation by Agr 16 (Fig. 5) . Then, we analyzed lysis of human neutrophils and erythrocytes as key mechanisms of aggressive S. aureus virulence. Agr, α -toxin, and PSMα peptides had a significant effect on neutrophil lysis (Fig. 6a) . The effect of Agr was particularly strong, in accordance with the fact that Agr controls expression of both hla and psmα 8, 22 . Erythrocyte lysis was strongly reduced in the agr and psmα deletion mutants, while deletion of hla showed no significant effect, in accordance with the known insensitivity of human erythrocytes to α -toxin 23 (Fig. 6b) . These findings attribute strong importance to α -toxin and PSMα peptides in lysing neutrophils and to PSMα peptides in lysing erythrocytes in the ST59 genetic background, as well as to Agr control in both these phenotypes. Then, we analyzed the impact agr, hla, and psmα have on virulence in murine skin, lung and blood infection models, using the isogenic gene deletion mutants. In the skin infection model, the agr and hla deletion mutants did not produce any abscesses, while abscesses caused by the psmα mutant were strongly reduced as compared to those caused by the wild-type strain (Fig. 7a,b) . In the bacteremia model, bacterial CFU in the kidneys were significantly reduced, by ~1 log, in all three mutants compared to the wild-type-infected mice (Fig. 8a ). Histological examination of liver and kidney tissue showed abscesses and pronounced infiltration of inflammatory cells in wild-type-infected mice, while these signs were largely absent from mice infected with the three mutant strains (Fig. 8b ). In the lung infection model, lung per body weight rations and bacterial loads were significantly reduced in mice infected with any of the three mutants as compared to mice infected with the wild-type strain (Fig. 9a,b) . Morphological examination of lungs showed reduction of enlargement and hyperemia, and histological examination of lung tissue reduced infiltration of erythrocytes and leukocytes in the mutant versus wild-type-infected lungs (Fig. 9c) . Interestingly, Agr and PSMα appeared to have a stronger impact on lung disease-related phenotypes than α -toxin. Altogether, significantly reduced pathology of the mutants in all three models demonstrated that α -toxin, PSMα peptides and Agr have a significant impact on these most important infection types caused by ST59 CA-MRSA.
Finally, we also investigated how the Chinese ST59 CA-MRSA isolates relate in virulence factor expression and virulence to CA-MRSA ST59 SSTI isolates obtained from the U.S. In the skin infection model, the Chinese isolates caused slightly, but significantly larger abscesses than the U.S. isolates, and showed similar pathology upon histological examination (Fig. 2a,b) . Furthermore, psmα , but not hla or RNAIII expression, was significantly higher in the Chinese ST59 than in the U.S. isolates (Fig. 3) . These findings are in accordance with the specific role of PSMα peptides as virulence determinants in skin infections, which was shown by animal and epidemiological studies 8, 24, 25 . Furthermore, they suggest that -while ST59 is a generally virulent CA-MRSA lineage -the Chinese ST59 isolates developed even further enhanced virulence due to increased expression of the psmα genes.
Discussion
The analysis of virulence determinants in CA-MRSA clones is an important prerequisite for the prioritization of targets for virulence-targeted drug development. The emergence of CA-MRSA clones with divergent genetic backgrounds in multiple geographic locations has made this analysis, originally focused almost exclusively on the U.S. clone USA300, particularly challenging. Our previous analysis of virulence factors using isogenic gene deletion mutants in the Korean clone ST72 12 to our knowledge is the only such analysis in a global CA-MRSA lineage performed as of yet; however, ST72 is of relatively limited geographic and clinical importance.
Here, we analyzed virulence and virulence determinants of a much more widespread CA-MRSA lineage, the predominant Asian CA-MRSA lineage ST59. As usually seen with CA-MRSA strains, CA-MRSA ST59 isolates had significantly more pronounced virulence in various animal infection models than the geographically matched HA-MRSA clones ST5 and ST239, which mirrors similar findings from our previous study that compared USA300 with common U.S. HA-MRSA clones 7 . Expression analyses showed increased expression of α -toxin, PSMs and the Agr regulator, which is in accordance with the notion that increased expression of these factors is characteristic for CA-MRSA 1, 7, 11 . Analysis of isogenic deletion mutants of those factors in in-vitro cytolysis assays demonstrated that PSMα peptides in ST59 CA-MRSA have a strong impact on lysis of neutrophils and erythrocytes, as previously shown for USA300 8 . α -toxin also showed a strong impact on neutrophil, but -as expected -not erythrocyte lysis. In animal skin, blood, and lung infection models, Agr, α -toxin, and PSMα had a strong effect on ST59 CA-MRSA pathogenesis.
Together with findings from previous studies that analyzed USA300 and ST72 gene deletion mutants in different animal models 8, 9, 12, 26, 27 , our results further emphasize that there are sometimes considerable differences in the relative contribution of even the core genome-encoded toxins to CA-MRSA virulence. For example, PSMα peptides had no significant impact on skin infection by ST72 12 , but a strong impact in the two clinically more important USA300 8, 26 and ST59 CA-MRSA. Furthermore, PSMα peptides were not as strong a contributor to virulence during severe lung infection in the USA300 background as PVL and α -toxin 27 , but here proved to be at least as important to the pathogenesis of lung infection as α -toxin. Currently, the reasons for these discrepancies between different strains are unknown. They do not seem to be due to expression differences, at least as far as what can be told from in-vitro expression levels. Differences may be due to differences in the animal models that were employed, in-vivo expression differences, and other, strain-specific toxins that may overshadow the effects of PSMα or α -toxin in a strain-dependent manner. Overall, our findings strongly support the notion that Agr and the genome-encoded toxins α -toxin and PSMα are important general contributors to CA-MRSA virulence. They emphasize that drug development efforts that are underway to target α -toxin [28] [29] [30] or the Agr regulator 31, 32 have high potential for the treatment of CA-MRSA infections and also call for including PSMα -targeting therapeutics in those endeavors. For the latter, blocking the recently discovered PSM transport system may bear great promise 33, 34 .
Methods Ethics statement. All animal experiments were performed following the Guide for the Care and Use of Laboratory Animals of the Chinese Association for Laboratory Animal Sciences (CALAS) with a protocol approved by the Committee on the Ethics of Animal Experiments of Renji Hospital (RJ-M-2014-0058).
Bacterial strains, plasmids, and growth conditions. Bacteria were identified as staphylococci by classic microbiological methods. S. aureus strains were further categorized by VITEK2 automated systems (BioMérieux, France). All strains and plasmids used in this study are listed in Table 1 . Escherichia coli was grown in Luria-Bertani medium. S. aureus was grown in tryptic soy broth (TSB) (Oxoid) with 0.25% glucose or on agar plates at 37 °C. Antibiotics were used at the following concentrations: ampicillin, 100 μ g/ml; chloramphenicol, 10 μ g/ml. Clinical U.S. ST59 SSTI CA-MRSA isolates were kindly provided by Binh Diep, University of California San Francisco 35 . Quantitative reverse-transcription (qRT) PCR. Total RNA was isolated using an RNeasy Mini Kit (Qiagen) from cells grown to late logarithmic growth phase (4 h) or stationary growth phase (8 h) in tryptic soy broth (TSB). Complementary DNA was synthesized from total RNA using the QuantiTect reverse transcription system (Qiagen) according to the manufacturer's instructions. The resulting complementary DNA and negative control samples were amplified using the QuantiTect SYBR green PCR kit (Qiagen). Reactions were performed in a MicroAmp Optical 96-well reaction plate using a 7500 Sequence Detector (Applied Biosystems). All qRT-PCR experiments were performed in triplicate, with gyrB as control. Oligonucleotides are listed in Table 2 .
Lysis of erythrocytes by culture filtrates. Culture filtrates were collected from bacterial cultures grown for 18 h. Hemolytic activities were determined by incubating samples with human red blood cells (2% v/v in Dulbecco's phosphate-buffered saline, DPBS) for 1 h at 37 °C. Hemolysis was determined by measuring the optical density at 540 nm using an ELISA reader. The assay was performed in triplicate.
Neutrophil lysis by bacteria. Human neutrophils were isolated from heparinized venous blood of healthy volunteers with a standard method. Bacteria grown to mid-logarithmic growth phase and neutrophils were incubated at a 10:1 ratio. PBS with 0.1% Triton-X100 (100 μ l) was used to determine 100% lysis. Lysis was measured using a lactate dehydrogenase (LDH) cytotoxicity detection kit according to the manufacturer's protocol (Roche).
Allelic gene replacement by homologous recombination and genetic complementation. For gene deletions in CA-MRSA ST59, a representative clinical isolate, RJ-2, was chosen, which was recovered from a 14 year-old female patient with severe SSTI. RJ-2 is lukSF-negative. The homologous recombination procedure using plasmid pKOR1 was performed as previously described 36 . Proper gene deletion was verified by analytical PCR and sequencing of the genomic DNA at the borders of the PCR-derived regions. Growth of the deletion mutants was similar to that of the wild-type strain. For genetic complementation of the hla mutation, the hla gene was PCR-amplified and cloned in the pTX Δ plasmid via BamH1 and Nar1 restriction sites. Strains containing the empty plasmid pTX Δ 16 were used as controls.
Determination of PSM concentrations. PSM concentrations in culture filtrates of cultures grown for 8 h were analyzed by reversed-phase high-pressure chromatography/ion spray mass spectrometry as described 37 .
Mouse infection models.
The mouse skin infection model was performed essentially as described else where 8 . Briefly, outbred, immunocompetent hairless female mice between 4 and 6 weeks of age were used. Anesthetized mice were inoculated with 50 μ l PBS containing ~10 7 live S. aureus or PBS alone in the back by subcutaneous injection. Abscess lengths and widths were measured with a caliper and abscess areas were calculated using the formula length × width. Paraffin embedding and hematoxylin & eosin (H&E) staining were performed as previously described 38 .
For the lung infection model, female BALB/c mice were used at 4-6 weeks of age. 4 × 10 9 CFU/40 μ l S. aureus was pipetted into the nares of the anesthetized mice. 48 h after inoculation, all mice were euthanized. The lungs from each group of animals were excised, weighed and washed with PBS, and one lobe was fixed in 4% formalin for histological examination (H&E stain). The other lobe was homogenized in 0.5 ml of PBS, and S. aureus CFU/g lung tissue was determined by plating 100 μ l homogenized lung tissue on TSB agar. For the bacteremia model, we used BALB/c female mice 4-6 weeks of age. We injected each mouse with 100 μ l PBS containing 10 7 CFU live S. aureus into the retro-orbital vein. Control animals received sterile PBS only. After inoculation, mouse health and disease advancement were monitored every day. Mice were euthanized immediately if they showed signs of respiratory distress, mobility loss or inability to eat and drink. All animals were euthanized 4 days after injection, the livers and kidneys were excised, washed with PBS, and fixed in 4% formalin for histological examination (H&E stain). One kidney of each animal was homogenized in 0.5 ml of TSB, and the homogenized kidney tissue was diluted and plated on TSB agar for CFU determination.
Statistics. Statistical analysis was performed using Graph Pad Prism 6.05. Data were analyzed using unpaired t tests to compare two different conditions and ANOVA for more conditions. All error bars show the standard error of the mean (SEM). All replicates are biological replicates. Table 2 . Oligonucleotides used in this study.
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